Search | WHO COVID-19 Research Database

1.

COVID-19: New vaccines under scrutiny.

Schlenger, R. L..

Deutsches Arzteblatt International ; 119(35-36):A1462-A1469 and A6, 2022.

Article in German | EMBASE | ID: covidwho-2280137

2.

COVID-19: New vaccines under scrutiny

Schlenger, R. L..

Deutsches Arzteblatt International ; 119(35-36):A1462-A1469 and A6, 2022.

Article in German | EMBASE | ID: covidwho-2125902

3.

COVID-19 Neue Impfstoffe auf dem Prüfstand

Schlenger, R. L..

Deutsches Arzteblatt International ; 119(35-36):A1462-A1469 and A6, 2022.

Article in German | Scopus | ID: covidwho-2125901

4.

Medikamente gegen COVID-19: Der lange Weg in die Praxis

Schlenger, R. L..

Deutsches Arzteblatt International ; 118(37), 2021.

Article in German | Scopus | ID: covidwho-1481713

5.

SARS-CoV-2: What distinguishes a superspreader

Schlenger, R. L..

Deutsches Arzteblatt International ; 118(11):A572-A573+A4, 2021.

Article in German | EMBASE | ID: covidwho-1407625

6.

Schlenger, R. L..

Deutsches Arzteblatt International ; 118(14):A-726, 2021.

Article in German | Scopus | ID: covidwho-1366128

7.

Antigen tests for SARS-CoV-2: The price of speed

Schlenger, R. L..

Deutsches Arzteblatt International ; 117(44):A2101-A2104, 2020.

Article in German | EMBASE | ID: covidwho-924868

8.

Antigentests auf SARS-CoV-2 Der Preis der Schnelligkeit

Schlenger, R. L..

Deutsches Arzteblatt International ; 117(44):A2101-A2104, 2020.

Article in German | Scopus | ID: covidwho-911360

9.

PCR tests for SARS-CoV-2: Interpreting results correctly

Schlenger, R. L..

Deutsches Arzteblatt International ; 117(24):A1194-A1195, 2020.

Article in German | EMBASE | ID: covidwho-815765